Veterinary Diagnostics Market Outlook: Rising Pet Ownership Boosts Diagnostic Demand

Veterinary Diagnostics Market to Accelerate as Preventive Animal Healthcare and Advanced Testing Technologies Expand

Market Estimation, Growth Drivers, and Opportunities

The global Veterinary Diagnostics Market was valued at USD 9.72 billion in 2025 and is projected to reach USD 23.99 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.56% from 2026 to 2034. The market is benefiting from increasing pet ownership, rising expenditure on animal healthcare, greater awareness of zoonotic diseases, and the growing need to monitor livestock health.

Veterinary diagnostics plays a critical role in identifying infectious diseases, metabolic disorders, hereditary conditions, and other health problems in companion animals and livestock. Rising demand for preventive veterinary care is encouraging clinics and laboratories to adopt advanced testing solutions that support earlier diagnosis and treatment decisions. The expansion of commercial livestock production and the need to protect food safety are also creating demand for reliable disease detection and surveillance.

Technological innovation is opening further opportunities through molecular diagnostics, automated analyzers, rapid point-of-care testing, and artificial intelligence-enabled interpretation. Portable testing systems can improve access to diagnostics in veterinary clinics and remote agricultural settings, while cloud-connected platforms can help practitioners manage results more efficiently. Companies that combine accuracy, speed, affordability, and easy-to-use testing systems are well positioned to benefit from the market’s expansion.

* Request Your Free Sample Copy:  https://www.maximizemarketresearch.com/request-sample/34589/ 

U.S. Market Trends and Investment in 2025

The United States continued to be an important center for veterinary diagnostic innovation in 2025, supported by advanced laboratory infrastructure, companion-animal healthcare spending, and government-backed disease surveillance. In January 2025, IDEXX Laboratories announced IDEXX Cancer Dx, a blood-based diagnostic panel initially designed to help detect lymphoma in dogs, with North American availability beginning in March. The test reflects growing interest in early cancer detection and the integration of diagnostic screening into routine veterinary care. Government investment also supported animal disease preparedness. According to the U.S. Department of Agriculture’s October 2025 National Animal Health Laboratory Network briefing, total FY2025 network funding reached approximately USD 43.16 million in allocated funding, including additional support for avian-health testing and emerging dairy-cattle disease investigations. These developments reinforce demand for laboratory capacity, rapid testing, and innovative diagnostic tools.

Market Segmentation: Leading Categories

According to the market report, immunoassays dominated the market by testing type in 2025. These tests are widely used to detect infectious diseases, hormones, and metabolic conditions. Their relatively rapid results, established clinical applications, and suitability for both laboratory and point-of-care settings support their adoption.

By end use, laboratories held the largest share, at approximately 49% in 2025. Veterinary laboratories support disease surveillance, confirmatory testing, research, quality assurance, and monitoring programs. Their role in identifying and tracking transboundary animal diseases makes them essential to veterinary healthcare systems.

Regionally, North America led the global market in 2025, benefiting from developed veterinary infrastructure, high levels of pet ownership, research investment, and established disease-monitoring programs.

Key Players
North America

1. IDEXX Laboratories Inc. (USA)
2. Zoetis Services LLC (USA)
3. Heska Corporation (USA)
4. Thermo Fisher Scientific, Inc. (USA)
5. Antech Diagnostics Inc. (Mars, Inc.) (USA)
6. VCA Animal Hospitals (Mars, Inc.) (USA)
7. Neogen Corporation (USA)

Europe
8. bioMérieux SA (France)
9. Virbac Corp (France)
10. Alvedia (France)
11. Randox Laboratories Ltd. (UK)
12. Biopanda Reagents (UK)
13. INDICAL BIOSCIENCE GmbH (Germany)
14. Fassisi GmbH (Germany)
15. QIAGEN N.V. (Germany)
16. Agrolabo S.p.A. (Italy)

Asia-Pacific
17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
18. Shenzhen Bioeasy Biotechnology Co. Ltd. (China)
19. BioNote Inc. (South Korea)
20. FUJIFILM Holdings Corporation (Japan)
21. IM3Vet Pty Ltd. (Australia)

Competitive Analysis: Major Companies and Innovation

The market report identifies IDEXX Laboratories, Zoetis, Heska, Thermo Fisher Scientific, and Antech Diagnostics among the major companies operating in the veterinary diagnostics landscape. The available report summary does not establish a verified market-share ranking for these five companies.

• IDEXX Laboratories, Inc. develops diagnostic instruments, laboratory services, and testing solutions for companion animals. Its 2025 Cancer Dx launch demonstrates the opportunity in earlier disease detection and preventive screening.
• Zoetis Inc. combines animal-health products with diagnostic capabilities. Its investment in veterinary healthcare and disease management positions it to serve companion-animal and livestock markets.
• Heska Corporation, now part of Mars Petcare, has a portfolio focused on veterinary diagnostic instruments, laboratory services, and point-of-care testing. Broader distribution and integration within veterinary care networks can support adoption.
• Thermo Fisher Scientific Inc. provides laboratory instruments, reagents, and molecular-testing technologies that can support veterinary disease research and diagnostic workflows.
• Antech Diagnostics, part of Mars Petcare, offers reference laboratory testing and diagnostic services. Its laboratory network and integration with veterinary practices support access to a broad range of tests.

Competition is increasingly shaped by diagnostic accuracy, turnaround time, test-menu breadth, automation, and the ability to integrate results into veterinary practice workflows.

Regional Analysis: Key Countries

United States: Advanced laboratories, pet healthcare expenditure, and USDA-supported disease surveillance underpin market growth. Early cancer detection and rapid infectious-disease testing create opportunities.

United Kingdom: Established veterinary services and animal disease surveillance support diagnostic demand. Continued focus on animal welfare, food safety, and infectious-disease monitoring encourages testing adoption.

Germany: Strong veterinary healthcare infrastructure and livestock production support demand for reliable diagnostics, particularly for infectious-disease monitoring and herd health management.